Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

18 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Immunotherapy in urothelial cancer: current status and future directions.
Piombino C, Tonni E, Oltrecolli M, Pirola M, Pipitone S, Baldessari C, Dominici M, Sabbatini R, Vitale MG. Piombino C, et al. Expert Rev Anticancer Ther. 2023 Jul-Dec;23(11):1141-1155. doi: 10.1080/14737140.2023.2265572. Epub 2023 Oct 27. Expert Rev Anticancer Ther. 2023. PMID: 37772970 Review.
Management of PALB2-associated breast cancer: A literature review and case report.
Toss A, Ponzoni O, Riccò B, Piombino C, Moscetti L, Combi F, Palma E, Papi S, Tenedini E, Tazzioli G, Dominici M, Cortesi L. Toss A, et al. Among authors: piombino c. Clin Case Rep. 2023 Aug 22;11(8):e7747. doi: 10.1002/ccr3.7747. eCollection 2023 Aug. Clin Case Rep. 2023. PMID: 37621724 Free PMC article.
Personalized Systemic Therapies in Hereditary Cancer Syndromes.
Mastrodomenico L, Piombino C, Riccò B, Barbieri E, Venturelli M, Piacentini F, Dominici M, Cortesi L, Toss A. Mastrodomenico L, et al. Among authors: piombino c. Genes (Basel). 2023 Mar 9;14(3):684. doi: 10.3390/genes14030684. Genes (Basel). 2023. PMID: 36980956 Free PMC article. Review.
Predictive factors for relapse in triple-negative breast cancer patients without pathological complete response after neoadjuvant chemotherapy.
Toss A, Venturelli M, Civallero M, Piombino C, Domati F, Ficarra G, Combi F, Cabitza E, Caggia F, Barbieri E, Barbolini M, Moscetti L, Omarini C, Piacentini F, Tazzioli G, Dominici M, Cortesi L. Toss A, et al. Among authors: piombino c. Front Oncol. 2022 Dec 1;12:1016295. doi: 10.3389/fonc.2022.1016295. eCollection 2022. Front Oncol. 2022. PMID: 36531080 Free PMC article.
Circulating and Intracellular miRNAs as Prognostic and Predictive Factors in HER2-Positive Early Breast Cancer Treated with Neoadjuvant Chemotherapy: A Review of the Literature.
Isca C, Piacentini F, Mastrolia I, Masciale V, Caggia F, Toss A, Piombino C, Moscetti L, Barbolini M, Maur M, Dominici M, Omarini C. Isca C, et al. Among authors: piombino c. Cancers (Basel). 2021 Sep 29;13(19):4894. doi: 10.3390/cancers13194894. Cancers (Basel). 2021. PMID: 34638377 Free PMC article.
Clinicopathologic Profile of Breast Cancer in Germline ATM and CHEK2 Mutation Carriers.
Toss A, Tenedini E, Piombino C, Venturelli M, Marchi I, Gasparini E, Barbieri E, Razzaboni E, Domati F, Caggia F, Grandi G, Combi F, Tazzioli G, Dominici M, Tagliafico E, Cortesi L. Toss A, et al. Among authors: piombino c. Genes (Basel). 2021 Apr 21;12(5):616. doi: 10.3390/genes12050616. Genes (Basel). 2021. PMID: 33919281 Free PMC article.
18 results